These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19887280)

  • 41. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
    Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
    Togioka BM; Schenning KJ
    Drugs Aging; 2022 Oct; 39(10):749-761. PubMed ID: 35934764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery].
    Øberg E; Claudius C
    Ugeskr Laeger; 2013 Feb; 175(7):428-32. PubMed ID: 23402253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents.
    Haerter F; Simons JC; Foerster U; Moreno Duarte I; Diaz-Gil D; Ganapati S; Eikermann-Haerter K; Ayata C; Zhang B; Blobner M; Isaacs L; Eikermann M
    Anesthesiology; 2015 Dec; 123(6):1337-49. PubMed ID: 26418697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sugammadex: a selective relaxant-binding agent providing rapid reversal.
    Rex C; Bergner UA; Pühringer FK
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):461-5. PubMed ID: 20489603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].
    Sparr HJ; Booij LH; Fuchs-Buder T
    Anaesthesist; 2009 Jan; 58(1):66-80. PubMed ID: 19082568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation.
    Paton F; Paulden M; Chambers D; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
    Br J Anaesth; 2010 Nov; 105(5):558-67. PubMed ID: 20935005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M
    Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU.
    Jones PM; Turkstra TP
    Anesth Analg; 2007 Sep; 105(3):877; author reply 878. PubMed ID: 17717257
    [No Abstract]   [Full Text] [Related]  

  • 53. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
    Zwiers A; van den Heuvel M; Smeets J; Rutherford S
    Clin Drug Investig; 2011; 31(2):101-11. PubMed ID: 21067251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
    de Boer HD; Carlos RV; Brull SJ
    BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Use of Sugammadex in a Patient With Guillain-Barre Syndrome: A Case Report.
    Tezcan B; Bölükbaşi D; Kazanci D; Turan S; Suer Kaya G; Özgök A
    A A Case Rep; 2017 Apr; 8(8):200-202. PubMed ID: 28151766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
    Eikermann M; Zaremba S; Malhotra A; Jordan AS; Rosow C; Chamberlin NL
    Br J Anaesth; 2008 Sep; 101(3):344-9. PubMed ID: 18559352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.